Woltering EA - Search Results

1

Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity.

Meyers MO, Anthony CT, Coy DH, Murphy WA, Drouant GJ, Fuselier J, Espenan GD, Maloney TJ, Woltering EA. Meyers MO, et al. Among authors: woltering ea. J Surg Res. 1998 May;76(2):154-8. doi: 10.1006/jsre.1998.5313. J Surg Res. 1998. PMID: 9698516

2

Metronomic dosing enhances the anti-angiogenic effect of epothilone B.

Stalder MW, Anthony CT, Woltering EA. Stalder MW, et al. Among authors: woltering ea. J Surg Res. 2011 Aug;169(2):247-56. doi: 10.1016/j.jss.2009.12.001. Epub 2009 Dec 30. J Surg Res. 2011. PMID: 20338584 Free PMC article.

3

The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogs.

Anthony CT, Hughey S, Lyons J, Weiss S, Hornick CA, Drouant GJ, Fuselier JA, Coy DH, Murphy WA, Woltering EA. Anthony CT, et al. Among authors: woltering ea. J Surg Res. 2004 Jun 1;119(1):1-13. doi: 10.1016/j.jss.2003.06.002. J Surg Res. 2004. PMID: 15126075

4

Synthesis and characterization of multiply-tyrosinated, multiply-iodinated somatostatin analogs.

Woltering EA, O'Dorisio MS, Murphy WA, Chen F, Drouant GJ, Espenan GD, Fisher DR, Sharma C, Diaco DS, Maloney TM, Fuselier JA, Nelson JA, O'Dorisio TM, Coy DH. Woltering EA, et al. J Pept Res. 1999 Feb;53(2):201-13. doi: 10.1111/j.1397-002x.1999.00019.x. J Pept Res. 1999. PMID: 10195457 Clinical Trial.

5

Suramin analogs inhibit human angiogenesis in vitro.

Meyers MO, Gagliardi AR, Flattmann GJ, Su JL, Wang YZ, Woltering EA. Meyers MO, et al. Among authors: woltering ea. J Surg Res. 2000 Jun 15;91(2):130-4. doi: 10.1006/jsre.2000.5920. J Surg Res. 2000. PMID: 10839961

6

Progressive nuclear translocation of somatostatin analogs.

Hornick CA, Anthony CT, Hughey S, Gebhardt BM, Espenan GD, Woltering EA. Hornick CA, et al. Among authors: woltering ea. J Nucl Med. 2000 Jul;41(7):1256-63. J Nucl Med. 2000. PMID: 10914919 Free article.

7

Antitumor and antiangiogenic effects of somatostatin receptor-targeted in situ radiation with (111)In-DTPA-JIC 2DL.

Gulec SA, Drouant GJ, Fuselier J, Anthony CT, Heneghan J, DelCarpio JB, Coy DH, Murphy WA, Woltering EA. Gulec SA, et al. Among authors: woltering ea. J Surg Res. 2001 May 15;97(2):131-7. doi: 10.1006/jsre.2001.6149. J Surg Res. 2001. PMID: 11341788

8

Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies.

Anthony LB, Woltering EA, Espenan GD, Cronin MD, Maloney TJ, McCarthy KE. Anthony LB, et al. Among authors: woltering ea. Semin Nucl Med. 2002 Apr;32(2):123-32. doi: 10.1053/snuc.2002.31769. Semin Nucl Med. 2002. PMID: 11965607 Clinical Trial.

9

In vitro modeling of the clinical interactions between octreotide and 111In-pentetreotide: is there evidence of somatostatin receptor downregulation?

Gunn SH, Schwimer JE, Cox M, Anthony CT, O'Dorisio MS, Woltering EA. Gunn SH, et al. Among authors: woltering ea. J Nucl Med. 2006 Feb;47(2):354-9. J Nucl Med. 2006. PMID: 16455643 Free article.

10

Development of a human cardiac tissue-based angiogenesis model.

Lewis JM, Anthony CT, Harrison LH, Ferguson TB, Andrew Heck H, Rubenstein F, Balster DA, Woltering EA. Lewis JM, et al. Among authors: woltering ea. J Surg Res. 2006 Sep;135(1):34-7. doi: 10.1016/j.jss.2006.02.051. J Surg Res. 2006. PMID: 16603188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page